Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Downgrades Avrobio to Equal-Weight, Lowers Price Target to $7

Morgan Stanley analyst Michael Ulz downgrades Avrobio (NASDAQ:AVRO) from Overweight to Equal-Weight and lowers the price target from $24 to $7.
byBenzinga Newsdesk
November 19, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Michael Ulz downgrades Avrobio (NASDAQ:AVRO) from Overweight to Equal-Weight and lowers the price target from $24 to $7.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0